BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 13, 2003
View Archived Issues
Company profile: Enact Pharma
Read More
Quinoline Src kinase inhibitors in AstraZeneca pipeline
Read More
Novel agents for enhancing DNA-damaging antitumor activity
Read More
Dual 5-HT reuptake inhibitors/5-HT1A agonists discovered at Wyeth
Read More
Lilly researchers claim piperidine-containing factor Xa inhibitors
Read More
Novel antidiabetic agents covered by Dr. Reddy's patent
Read More
Merck presents new aldose reductase inhibitors
Read More
Novel series of antiangiogenic tyrosine kinase inhibitors for cancer and other disorders
Read More
Merck presents new antithrombotic thrombin receptor antagonists
Read More
BMS claims buspirone metabolite enantiomers with utility in anxiety and depression
Read More
XenoPort receives SBIR grant to aid in identification of drug transport pathways
Read More
Schwarz's year-end results exceed expectations
Read More
Sumitomo licenses Glucophage in Japan
Read More
Vical anthrax vaccine to enter clinical testing by year-end 2003
Read More
Potential use of abetimus sodium in the prevention of SLE-associated renal flare
Read More
Gadobutrol perfusion-weighted imaging in Alzheimer's disease
Read More
Transarterial 131I-lipiodol in HCC
Read More
Ariad focuses resources on anticancer candidates
Read More
Prevention of angina attacks by ivabradine
Read More
ACAM-2000 completes phase I trial
Read More
Omalizumab reduces the incidence of exacerbations in allergic asthma
Read More
Hybridon's IMO compounds show activity in preclinical models of allergic asthma
Read More
Catalyst Pharmaceutical will seek licenses for NM-702
Read More
Gadofosveset sodium improves MRA accuracy and patient management in PVD
Read More
Promising results emerge from phase II study of DP-b99 in stroke
Read More
Boston Scientific and Osiris form stem cell alliance
Read More
Mutual recognition procedure successfully completed for Crestor
Read More